Qing, Shui-Wang <br/><br/>
Dose escalation of Stereotactic Body Radiotherapy (SBRT) for locally advanced unresectable pancreatic cancer patients with CyberKnife: protocol of a phase I study.  [electronic resource] 

 -  Radiation oncology (London, England)  Jan 2017 
 - 6 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article 
<br/><br/><label>ISSN: </label>1748-717X 
<br/><br/><label>Standard No.: </label>10.1186/s13014-016-0760-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Female<br/>Humans<br/>Male<br/>Maximum Tolerated Dose<br/>Middle Aged<br/>Pancreatic Neoplasms--radiotherapy<br/>Radiosurgery--methods<br/>Radiotherapy Dosage<br/>Research Design